<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04172168</url>
  </required_header>
  <id_info>
    <org_study_id>9215443689</org_study_id>
    <nct_id>NCT04172168</nct_id>
  </id_info>
  <brief_title>Left Ventricular Free-wall Ruptrue After Acute Myocardial Infarction (LVFR-AMI)</brief_title>
  <official_title>Clinical Characteristics of Left Ventricular Free-wall Ruptrue After Acute Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiamen Cardiovascular Hospital, Xiamen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xiamen Cardiovascular Hospital, Xiamen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Left Ventricular Free-wall Ruptrue (LVFR) is a serious complication caused high
      mortality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The actual mortality of LVFR is close to 100%. Despite the mortality rate for LVFR has been
      decreasing with the development of reperfusion therapy, the serious complication remains a
      difficult challenge. The coronary anatomy distribution associated with LVFR has an
      interesting phenomenon. From the perspective of different coronary distribution, we can
      better known the risk factors related to LVFR.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2011</start_date>
  <completion_date type="Anticipated">January 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of heart ruputre</measure>
    <time_frame>Mortality 30 days</time_frame>
    <description>Left Ventricular Free-wall Ruptrue</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of cardiogenic shock</measure>
    <time_frame>Hospitalization 30 days</time_frame>
    <description>Cardiogenic shock After AMI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of cardiac arrest</measure>
    <time_frame>Hospitalization 30 days</time_frame>
    <description>Cardiac arrest After AMI</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">17568</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Heart rupture</arm_group_label>
    <description>Include left ventricular free-wall ruptrue after AMI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non heart rupture</arm_group_label>
    <description>AMI with non heart rupture</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Heart rupture</intervention_name>
    <description>Left ventricular free-wall ruptrue after AMI</description>
    <arm_group_label>Heart rupture</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population of acute myocardial infarction (STEMI or NSTEMI) patients.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients be admitted for acute myocardial infarction (STEMI or NSTEMI)

        Exclusion Criteria:

          -  Non-cardiovascular comorbidity for AMI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan Wang, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Cardiovascular Hospital, Xiamen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yan Wang, PhD</last_name>
    <phone>+8613860488088</phone>
    <email>wy@medmail.com.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bin Wang, PhD</last_name>
    <phone>+8613400664305</phone>
    <email>mocw361@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Xiamen Cardiovascular Hospital Xiamen University</name>
      <address>
        <city>Xiamen</city>
        <state>Fujian</state>
        <zip>361000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bin Wang, Ph.D</last_name>
      <phone>+8613400664305</phone>
      <email>mocw361@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 18, 2019</study_first_submitted>
  <study_first_submitted_qc>November 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2019</study_first_posted>
  <last_update_submitted>November 20, 2019</last_update_submitted>
  <last_update_submitted_qc>November 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xiamen Cardiovascular Hospital, Xiamen University</investigator_affiliation>
    <investigator_full_name>Yan Wang</investigator_full_name>
    <investigator_title>President</investigator_title>
  </responsible_party>
  <keyword>Left Ventricular Free-wall Ruptrue</keyword>
  <keyword>Acute myocardial infarction</keyword>
  <keyword>Coronary angiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

